drugset
drugset / Trial / NCT00141570

Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women

NCT00141570 ↗

Phase 2 Completed 350 enrolled Solvay Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine whether treatment with ESTRATEST® H.S. Tablets is superior to treatment with esterified estrogens tablets

Timeline

Start
2004-06
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ESTROGENS, ESTERIFIED Unknown 0.625 mg —
Subject methyltestosterone Small molecule 1.25 mg —

Indications

No indication recorded.